The Hair Loss Encyclopedia

Search

for
Search:

GlossarySecukinumab

biologic medication treating autoimmune conditions by inhibiting interleukin-17A

Secukinumab is a biologic medication used to treat autoimmune conditions such as psoriasis, ankylosing spondylitis, and psoriatic arthritis. It works by inhibiting interleukin-17A, a protein that plays a key role in the inflammatory process, thereby reducing inflammation and helping to control symptoms.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 128 results

Repigmentation and New Hair Growth After Anti-Interleukin-17 Therapy with Secukinumab for Psoriasis

research Repigmentation and New Hair Growth After Anti-Interleukin-17 Therapy with Secukinumab for Psoriasis

12 citations, May 2018 in “JAAD Case Reports”

A man's gray hair got darker and thicker after using a psoriasis drug.

research Successful Treatment of Refractory Folliculitis Decalvans with Secukinumab

10 citations, October 2019 in “Australasian Journal of Dermatology”

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Generalized Hypertrichosis Due to Secukinumab in a Patient with Moderate Psoriasis: A Case of Serendipity or Zemblanity?

research Generalized Hypertrichosis Due to Secukinumab in a Patient with Moderate Psoriasis: A Case of Serendipity or Zemblanity?

5 citations, April 2019 in “Dermatologic therapy”

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Excessive Hair Growth in a Patient with Psoriatic Erythroderma Following Secukinumab Administration

research Excessive Hair Growth in a Patient with Psoriatic Erythroderma Following Secukinumab Administration

3 citations, July 2018 in “European Journal of Dermatology”

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis

research Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis

1 citations, October 2023 in “Clinical, cosmetic and investigational dermatology”

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

View more "secukinumab" in research →

Community Join

0 / 0 results

— no results